Details Matter….

Uterine leiomyomas are the most common benign tumors of the female reproductive system and can be found in up to 80% of women (1). Uterine fibroids can cause significant morbidity, including heavy menstrual bleeding, pelvic pain, urinary frequency, constipation, and represent a common cause of infertility. Hysterectomy provides a definitive treatment at the expense of losing the organ and the prospect of future fertility. Choosing the ideal therapeutic option for patients with symptomatic fibroids presents a clinical dilemma frequently faced by the patient and her gynecologist. This issue of JMIG includes two studies that shed some light that will aid in shared decision-making for MIGS surgeons and the patient with symptomatic uterine fibroids. Attitudes and Beliefs about Hysterectomy in Patients with Uterine FibroidsJournal of Minimally Invasive GynecologyPreviewTo investigate the attitudes toward and beliefs about hysterectomy that influence the decision of women with symptomatic uterine fibroids regarding hysterectomy. Full-Text PDF Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine FibroidsJournal of Minimally Invasive GynecologyPreviewIncreasing evidence suggests that hysterectomy to treat uterine fibroids (UFs), even with ovarian conservation (OC), is associated with a 33% increased risk of coronary artery disease (CAD). We sought to compare the cost-effectiveness of various treatment approaches for UFs to understand the trade-offs among development of CAD vs new fibroids. Full-Text PDF